In the mice house dust mite (HDM) model of ACD, it was discovered that the administration of the TRPV1 antagonist, PAC-14028, reduced scratching and improved skin barrier function and recovery [61,62]. The gene discussed is TRPV1; the disease is granular corneal dystrophy type II.